Clinical Trials Browser

NIH × amivantamab × 1 year × Clear all

NCT07042295 2026-06-03

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

Phase 2 Suspended

Locally Recurrent Skin Squamous Cell Carcinoma